Ophthalmology Doctors in Westlake, OH Accepting Medicare

6 Ophthalmology doctors found. Showing 1 - 6

George W Rozakis, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 29111 Center Ridge Rd, Westlake, OH 44145 Phone: 440-777-2667    Fax: 440-835-2266

Charles Kutina, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 25200 Center Ridge Rd, Suite 1200, Westlake, OH 44145 Phone: 440-331-3047    Fax: 440-331-3084

Elisa Bala, MD, MSC Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 22984 Westwood Rd, Westlake, OH 44145 Phone: 216-235-1135

Darrell White, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2237 Crocker Rd, Suite 100, Westlake, OH 44145 Phone: 440-892-3931

Mary Ann Lavery, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 27059 Center Ridge Rd, Westlake, OH 44145 Phone: 440-871-8933    Fax: 440-899-9462

Dr. Robert Martin Stern, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 850 Columbia Rd, Westlake, OH 44145 Phone: 440-899-2288

News Archive

New eye test objectively measures level of fatigue that doctors may feel after long shifts

An international team of scientists which includes researchers from the U. of Granada has demonstrated for the first time that it is possible to establish in an objective way the level of fatigue in physicians after long shifts through their eye movement.

Drunkorexia may affect long-term health of college students

It is well known that eating disorders are common among teens and college students. Heavy alcohol consumption is another well-known unhealthy habit of this age group. A new study from the University of Missouri shows that when college students combine these two unhealthy habits, their long-term health may be affected. "Drunkorexia" is a new term coined by the media to describe the combination of disordered eating and heavy alcohol consumption.

DARA BioSciences submits KRN5500 Orphan Drug Application with FDA

DARA BioSciences, Inc., a specialty pharmaceutical company focused on oncology and oncology supportive care products, announced today it has submitted an Orphan Drug Application to the U.S. Food and Drug Administration (FDA) for KRN5500, a compound in development to treat a painful form of chronic chemotherapy-induced peripheral neuropathy (CCIPN).

Lower outdoor temperature associated with 2% increase in heart attack risks

Lower outdoor temperatures are linked to an increase in the risk of heart attacks, according to a new study by scientists at the London School of Hygiene & Tropical Medicine (LSHTM).For the study (published in the British Medical Journal and released online today at bmj.com), the researcher, led by Krishnan Bhaskaran of LSHTM found that each 1°C reduction in temperature on a single day is associated with around 200 extra heart attacks.

Read more Medical News

› Verified 9 days ago